The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

Should advocates be trying now to get a US rituximab trial started?

Discussion in 'Advocacy Projects' started by Sasha, Jul 7, 2015.

  1. Sasha

    Sasha Fine, thank you

    Messages:
    12,778
    Likes:
    34,181
    UK
    In the light of last week's new paper out of Norway supporting the exciting results of the earlier RCT of rituximab for PWME, should US advocates be trying to get a US rituximab trial underway now?

    On another thread, UK MEA medical advisor Dr Charles Shepherd (who has ME himself) said:

    Interested in your thoughts about the US, @charles shepherd, @Jonathan Edwards, @Simon...
     
    justy, Hutan, lycaena and 6 others like this.
  2. heapsreal

    heapsreal iherb 10% discount code OPA989,

    Messages:
    8,879
    Likes:
    8,179
    australia (brisbane)
    I think australia would also be well suited to a rituximab trial through the cfsme researchers at griffith university, who are in partnership with the government health system here (Queensland Health). With some of the world's best cancer researchers here, it would be well within their capacity to do some good research , trials and treatments .
     
    AndyPandy, justy, Hutan and 8 others like this.
  3. Simon

    Simon

    Messages:
    1,919
    Likes:
    14,452
    Monmouth, UK
    added: Cort's bit on the US situation, quoted by @Sasha

    Yes - though not just advocates, very happy if some clincian/researchers pick this up instead though suspect pressure from both will help.

    Though I suspect NIH/MRC won't actually sign up til there are results from Norway (they might accept provisional results from F&M, don't know); the pre-trial work on b-cell subtypes in the UK might help too.. They may also be willing to fund the work in preparing the detailed plans for such a large-scale study - sometimes that sort of thing gets funded too, as it takes a huge amount of work.

    Sorry, thinking aloud here. Yes, I do think we and researchers/clinicians in US, UK (and anywhere else eg Oz) should think seriously about this, even if the most likely short-term outcomes is funding for preparation for a large scale study - pending results from elsewhere. It could still take a year or two off the time it takes to get results from such full studies, i.e. cut the time before the drug is available to patients generally (assuming the initial good results pan out).
     
    Last edited: Jul 7, 2015
    leokitten, Hutan, catly and 4 others like this.
  4. heapsreal

    heapsreal iherb 10% discount code OPA989,

    Messages:
    8,879
    Likes:
    8,179
    australia (brisbane)
    The Australian cfs researchers have been interested in rituximab for a long time and have been following the Norwegian research very early on.

    They have invested most of their research time in finding a diagnostic test. It wouldn't suprise me if once norway have their research completed, it wont take long at all for them to have a test and probably already have a good idea on how rituximab actually works in cfs.

    Delays in treatment trials here would be more related to politics and lack of understanding , which i think is why they have proceeded in looking for physiological abnormalities, biomarkers etc to help prove ME exists but also possibly to show improvements from treatment,not just going by how one says they feel.

    Its good to have many countries involved. I think once its sorted, everything will fall into place, i hope.
     
    catly, barbc56, Sasha and 1 other person like this.
  5. EtherSpin

    EtherSpin Senior Member

    Messages:
    169
    Likes:
    223
    Melbourne , Australia
    In the meantime I'm keen to do anything to advocate for a trial and hasten it (as I've detailed in some ideas in the Aussie Ritux thread ) - I think its possible for researchers to glean data without necessarily conducting their own full study - getting CFS docs here to monitor and of their patients who qualify for Ritux here for other conditions like Rheumatoid Arthritis . we have what.. over 200000 CFS people here ? that should be enough with R.A. to observe for example if their docs guided them through a ritux protocol.
     
    heapsreal, catly, barbc56 and 2 others like this.
  6. Sasha

    Sasha Fine, thank you

    Messages:
    12,778
    Likes:
    34,181
    UK
    @Jonathan Edwards, do you think this idea has value? If so, this is something that should be being done in every country.
     
    catly and barbc56 like this.
  7. alex3619

    alex3619 Senior Member

    Messages:
    12,480
    Likes:
    35,011
    Logan, Queensland, Australia
    The other thing is countries can have plans ready to go, and consult with the Norwegian team, before final commitment. This would be an in-between position. I do think that some other countries need to get studies started, even if they are smaller ones than Norway.
     
    justy and Sasha like this.
  8. Jonathan Edwards

    Jonathan Edwards "Gibberish"

    Messages:
    5,227
    Likes:
    31,871
    I certainly think it would be useful to document any cases given rituximab for other conditions who have coexisting ME. That may not always be easy to tease out but in some cases it should be. Nielk is a case in point. Unfortunately, since rituximab is only one of many treatments for RA we may be talking about one person in a million having rituximab for RA while also having ME. There should still be a few dozen around the world.
     
    justy and Sasha like this.
  9. Sasha

    Sasha Fine, thank you

    Messages:
    12,778
    Likes:
    34,181
    UK
    I don't want to derail the thread (which is about a US trial for rtx) but aren't Fluge & Mella also looking at cyclophosphamide (also used in RA) - can't remember if they're also looking at methotrexate (another RA drug)? If these other RA drugs would be expected to have a similar mechanism of action (including on T-cells, not just B-cells?) shouldn't we be looking at PWME getting treated with all of them for their RA? And their cancer? That would certainly bump the numbers up.
     
    Persimmon likes this.
  10. Scarecrow

    Scarecrow Revolting Peasant

    Messages:
    1,891
    Likes:
    5,328
    Scotland
    In theory this sounds great but how could you monitor it? (Costs / communication / organisation)
     
    Sasha likes this.
  11. Sasha

    Sasha Fine, thank you

    Messages:
    12,778
    Likes:
    34,181
    UK
    That would be my next question! First question is whether it's worth doing, in theory... :cool:
     
    Scarecrow and catly like this.
  12. SOC

    SOC

    Messages:
    7,802
    Likes:
    16,462
    Would the protocol be the same for RA or cancer and ME? If so, this could be useful, if not, it might be difficult to understand whether these drugs would help with ME or not. One condition may need higher dose, more frequent dosing, more repeated doses over longer time than another. If the RA treatment, for example, wasn't long enough to affect ME, then it would look like the treatment (given for RA) doesn't work for ME, when it might given the correct protocol. Or if the dose for some other condition was higher than needed for ME, the side effects might be worse and considered too much for PWME. If the protocols are exactly the same regardless of the condition being treated, these questions are all moot. :)

    Nevertheless, it would be interesting to see if any clues can be extracted by gathering such information. It may be that the information is more vague and fuzzy than we would like. Clues can be valuable, but we know how good Certain People are at misinterpreting fuzzy data and using it against us. :cautious:
     
    Last edited: Jul 7, 2015
    Hutan, Scarecrow, Kyla and 1 other person like this.
  13. Nielk

    Nielk

    Messages:
    6,877
    Likes:
    10,608
    If the goal is complete B cell depletion, couldn't this be monitored via blood test? As an example, I was given two infusions of Rituximab over a year ago for my RA. Two months later my CD 19 was 0. The depletion has lasted all year long. I am assuming that subsequent doses would have been useless, since there wereni B cells to kill. Why is there an assumption that all patients in a disease group will react the same way in reducing their B cells?
     
    EtherSpin and Hutan like this.
  14. Hutan

    Hutan Senior Member

    Messages:
    1,069
    Likes:
    6,427
    New Zealand
    (sorry, further derailing the thread but perhaps relevant to the question about how rituximab treatment regimes differ for different diseases)

    Hope you don't mind me using your case as an example @Nielk. It was so generous of you to share your experience with rituximab with us. I have been wondering if the treatment regime you followed for RA (two infusions only) was responsible for your lack of response regarding ME symptoms.

    I think one non-responder in the first Norwegian trial responded in the second. I wonder what happened with the Norwegian trial patients' B cells over the trial period. Is that reported anywhere?

    I wonder if the timing of B cell elimination tells us anything abut who responds. Is it possible that Nielk's plasma cells and/or specific antibodies persisted longer, even though the B cells that made the plasma cells were long gone?

    I wonder if rituximab is actually doing something else, other than eliminating B cells, that helps ME patients. And so Nielk, if you had had a longer course, like that of the Norwegian patients, perhaps this other effect of rituximab might have kicked in.
     
    Last edited: Jul 7, 2015
    nandixon, catly, Nielk and 1 other person like this.
  15. charles shepherd

    charles shepherd Senior Member

    Messages:
    2,238
    Likes:
    16,189
    I raised my observations (at the start of this thread) on the need for a large (ideally multicentre) UK RCT sooner rather than later as an agenda item at the UK Research Collaborative Board meeting on Wednesday this week

    And there was actually a lot of support for trying to get something moving here in the UK right now, and not just waiting to do this until the Norwegian phase 3 trial has finished (in summer 2017) and been reported on (presumably in 2018).
     
    BurnA, Jenny, justy and 7 others like this.
  16. charles shepherd

    charles shepherd Senior Member

    Messages:
    2,238
    Likes:
    16,189
    There are other major funders here in the UK who could fund a large RCT - possibly with the charity sector as co-funders….
     
    justy, Debbie23, Indigophoton and 3 others like this.
  17. Sasha

    Sasha Fine, thank you

    Messages:
    12,778
    Likes:
    34,181
    UK
    What sort of funders?
     
    Scarecrow likes this.
  18. Sasha

    Sasha Fine, thank you

    Messages:
    12,778
    Likes:
    34,181
    UK
  19. barbc56

    barbc56 Senior Member

    Messages:
    3,652
    Likes:
    5,006
    Fog horns sounding. I thought @Jonathan Edwards is setting up a trial in the UK? Possibly, consulting with Norway.

    If I weren't so exhausted, I would try and find it.

    Can anyone help?

    Barb
     
    Kati likes this.
  20. charles shepherd

    charles shepherd Senior Member

    Messages:
    2,238
    Likes:
    16,189
    Difficult to do on an intentional basis but I think it would be extremely helpful if we had some form of registry that contained details of people with ME/CFS who have been prescribed Rituximab (for ME/CFS, or for another condition) outside a clinical trial setting

    There are certainly some people here in the UK that I am aware of and I suspect that there may now be a rather more significant number in America
     
    Hutan likes this.

See more popular forum discussions.

Share This Page